GPX4 and cancer: We found that a significant decrease of GPX4 activity was observed for Zn2+ or Zn-Fu MNs treated cancer cells, in contrast to PBS or Fu group, suggesting the great inactivation of GPX4, induced by Zn2+ or Zn-Fu MNs.